Ep.221: Alex (@aebridgeman) is joined by Moises Eilemberg (@Meilemberg). My guest is Moises Eilemberg, CEO of XiltriX, a 24-7 life science asset monitoring business that started 5 years ago with 36 employees today and growing swiftly. Moises is unique in that this is his second time as a CEO, his first being back in 2006 when he acquired a healthcare revenue cycle management company Avadyne, which he ran for 11 years before exiting, making 4 add-on acquisitions during that time. Moises has a ton of experience to share leading teams, improving unit economics, building sales orgs, and managing the change that comes with integrating add-on acquisitions. Listen weekly and follow the show on Apple Podcasts, Spotify, Google Podcasts, Stitcher, Breaker, and TuneIn.  Learn more about Alex and Think Like an Owner at https://tlaopodcast.com/ I want to tell you about the audience survey we are currently running. These surveys help us create the best content for listeners and better understand your needs and interests. Thank you in advance for sharing your feedback, we greatly appreciate it.  Take the survey here: https://bit.ly/3QLBB1N Links: XiltriX Moises on LinkedIn Topics: (00:00:00) - Intro (00:04:20) - Moises’ career & XiltriX (00:07:02) - Becoming comfortable with the CEO role (00:09:33) - When did you start acquiring companies? (00:12:35) - How did your integration process change as you acquired more companies? (00:22:14) - Is there a reason you chose to be in this industry? (00:25:27) - What is the state of your market today? (00:29:12) - Is the market fragmented to a point where there are M&A opportunities? (00:31:40) - What’s driving the biologics growth over the past few years? (00:33:30) - What did you apply from your experience at Avadyne into XiltriX? (00:36:44) - What was your experience setting Sales comps? (00:42:57) - What levers have you used to improve unit economics?